Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
27.27
+0.59 (2.21%)
May 6, 2026, 2:01 PM EDT - Market open
Zymeworks Employees
Zymeworks had 264 employees as of December 31, 2025. The number of employees decreased by 22 or -7.69% compared to the previous year.
Employees
264
Change (1Y)
-22
Growth (1Y)
-7.69%
Revenue / Employee
$401,383
Profits / Employee
-$307,311
Market Cap
2.01B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 264 | -22 | -7.69% | 264 | 0 |
| Dec 31, 2024 | 286 | 8 | 2.88% | 280 | 6 |
| Dec 31, 2023 | 278 | -16 | -5.44% | 272 | 6 |
| Dec 31, 2022 | 294 | -164 | -35.81% | 291 | 3 |
| Dec 31, 2021 | 458 | 103 | 29.01% | 455 | 3 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ascentage Pharma Group International | 767 |
| Harmony Biosciences Holdings | 293 |
| Capricor Therapeutics | 231 |
| Pharvaris | 129 |
| Aurinia Pharmaceuticals | 128 |
| Inhibrx Biosciences | 110 |
| AnaptysBio | 104 |
| Taysha Gene Therapies | 99 |
ZYME News
- 14 days ago - Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026 - GlobeNewsWire
- 15 days ago - Zymeworks Transcript: 2026 Bloom Burton & Co. Healthcare Investor Conference - Transcripts
- 18 days ago - Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform - GlobeNewsWire
- 20 days ago - Zymeworks to Report First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026 - GlobeNewsWire
- 21 days ago - Zymeworks Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 27 days ago - Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth - GlobeNewsWire
- 5 weeks ago - Zymeworks Appoints Kristin Stafford as Chief Financial Officer - GlobeNewsWire
- 5 weeks ago - Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate - GlobeNewsWire